报价延迟最少15分钟:2025/07/07 00:56 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.03 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
0.08/-0.30
|
|
企业价值
43.25M
|
| 资产负债 |
|
每股账面净值
0.88
|
| 现金流量 |
|
现金流量率
0.01
|
| 损益表 |
|
收益
14.16M
|
|
每股收益
1.15
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2025/07/07 00:56 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. Incommercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues. |